Thymosin Alpha-1 (Tα1 / Zadaxin)

The Thymus and Immune Ageing

The thymus — a small gland behind the sternum — is the training ground for T-lymphocytes. Naive T-cells from bone marrow migrate to the thymus where they mature, learn to distinguish self from non-self, and gain functional specialisation. The thymus is essential for adaptive immune competence.

The tragedy of thymic biology is its rapid involution: thymic mass peaks in early childhood and declines progressively, losing approximately 3% of functional tissue per year after puberty. By age 65, over 80% of the thymus has been replaced by fat. The consequence is immunosenescence — declining T-cell diversity and function, impaired vaccine response, increased cancer risk, and systemic inflammatory ageing (inflammaging).

Thymosin Alpha-1 was isolated from thymic tissue by Allan Goldstein in the 1970s and represents the thymus's principal active signalling peptide.

Mechanism of Action

Tα1 binds to Toll-like receptors (TLR-2, TLR-9) on dendritic cells and T-cells, producing a cascade of immunomodulatory effects: ^[]

• T-cell differentiation — promotes maturation of immature thymocytes
• Dendritic cell activation — enhances antigen presentation
• Th1 polarisation — promotes cell-mediated immunity over antibody responses
• NK cell activation — enhances natural killer cell cytotoxicity
• mTOR and autophagy modulation — restores immune cell metabolic function

Critically, Tα1 modulates rather than uniformly stimulates or suppresses. In immunodeficient states, it boosts immune function. In hyperactive states (certain autoimmune contexts), it can dampen excessive responses. This homeostatic property makes it safer than broad immunostimulants.

Clinical Evidence

Hepatitis B and C: Multiple RCTs in Asia show Tα1 combined with standard antiviral therapy significantly improves viral clearance rates compared to antiviral alone. ^[]

COVID-19: A retrospective study of 76 severe COVID-19 patients in China found Tα1 treatment associated with significantly lower 28-day mortality (11% vs. 31%) compared to matched controls — prompting extensive interest. ^[]

Cancer adjuvant: Phase 2 data shows Tα1 improves survival and quality of life in lung cancer patients receiving chemotherapy, likely via restoration of chemotherapy-suppressed immune function.

Thymosin Alpha-1 vs. Thymalin

Both derive from the thymus but differ significantly. Thymalin is a crude polypeptide extract from bovine thymus — containing Tα1 and other thymic peptides. Tα1 is a pure, synthetic, fully characterised single peptide with defined pharmacology. For clinical predictability, Tα1 is preferred; for broader thymic restoration, the combination is used in Russian longevity protocols.